A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

Recruiting

Back to Lupus Erythematosus, Systemic trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(93 sites)

United States

University Of Alabama, Birmingham, Alabama

Loma Linda University, San Bernardino, California

UCSF, San Francisco, California

Sutter Health Network, San Pablo, California

Ann and Robert H Lurie Childs Hosp, Chicago, Illinois

Northwestern University, Chicago, Illinois

University Of Iowa, Iowa City, Iowa

University of Kentucky, Lexington, Kentucky

Tufts Medical Center, Boston, Massachusetts

Boston Medical Center, Boston, Massachusetts

WA Uni School Of Med, St Louis, Missouri

Oregon Health Sciences University, Portland, Oregon

Univ Of TX MD Anderson CC, Houston, Texas

University of Texas MD Anderson Cancer Center, Houston, Texas

LDS Hospital, Salt Lake City, Utah

Australia

Novartis Investigative Site, Clayton, Victoria

Austria

Novartis Investigative Site, Graz

Novartis Investigative Site, Vienna

Brazil

Novartis Investigative Site, Salvador, Estado de Bahia

Novartis Investigative Site, Barretos, São Paulo

Novartis Investigative Site, São Paulo, São Paulo

Novartis Investigative Site, São Paulo

Czechia

Novartis Investigative Site, Olomouc

Novartis Investigative Site, Prague

Denmark

Novartis Investigative Site, Aarhus N

France

Novartis Investigative Site, Bordeaux

Novartis Investigative Site, Marseille

Novartis Investigative Site, Nantes

Novartis Investigative Site, Paris

Novartis Investigative Site, Strasbourg

Novartis Investigative Site, Toulouse

Novartis Investigative Site, Vandœuvre-lès-Nancy

Germany

Novartis Investigative Site, Stuttgart, Baden-Wurttemberg

Novartis Investigative Site, Frankfurt am Main, Hesse

Novartis Investigative Site, Cologne, North Rhine-Westphalia

Novartis Investigative Site, Leipzig, Saxony

Novartis Investigative Site, Jena, Thuringia

Novartis Investigative Site, Essen

Novartis Investigative Site, Mainz

Novartis Investigative Site, Nuremberg

Novartis Investigative Site, Ulm

Hungary

Novartis Investigative Site, Debrecen, Hajdu Bihar Megye

Novartis Investigative Site, Budapest

Israel

Novartis Investigative Site, Ramat Gan

Italy

Novartis Investigative Site, Alessandria, AL

Novartis Investigative Site, Ancona, AN

Novartis Investigative Site, Genova, GE

Novartis Investigative Site, Milan, MI

Novartis Investigative Site, Rozzano, MI

Novartis Investigative Site, Pescara, PE

Novartis Investigative Site, Pisa, PI

Novartis Investigative Site, Pavia, PV

Japan

Novartis Investigative Site, Sapporo, Hokkaido

Novartis Investigative Site, Kobe, Hyōgo

Novartis Investigative Site, Kanazawa, Ishikawa-ken

Novartis Investigative Site, Yokohama, Kanagawa-ku

Novartis Investigative Site, Sendai, Miyagi

Novartis Investigative Site, Suita, Osaka

Novartis Investigative Site, Izumo, Shimane

Novartis Investigative Site, Bunkyo Ku, Tokyo

Novartis Investigative Site, Bunkyo-ku, Tokyo

Novartis Investigative Site, Chiba

Novartis Investigative Site, Fukuoka

Novartis Investigative Site, Kyoto

Netherlands

Novartis Investigative Site, Leiden, South Holland

Novartis Investigative Site, Groningen

Novartis Investigative Site, Utrecht

Norway

Novartis Investigative Site, Oslo

Romania

Novartis Investigative Site, Bucharest

Saudi Arabia

Novartis Investigative Site, Riyadh

Singapore

Novartis Investigative Site, Singapore

South Korea

Novartis Investigative Site, Seoul

Spain

Novartis Investigative Site, Santiago Compostela, A Coruna

Novartis Investigative Site, Santander, Cantabria

Novartis Investigative Site, Pamplona, Navarre

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Córdoba

Novartis Investigative Site, Madrid

Novartis Investigative Site, Salamanca

Novartis Investigative Site, Valencia

Sweden

Novartis Investigative Site, Stockholm

Switzerland

Novartis Investigative Site, Lausanne

Taiwan

Novartis Investigative Site, Taichung

Novartis Investigative Site, Taipei

United Kingdom

Novartis Investigative Site, Sheffield, South Yorkshire

Novartis Investigative Site, London

View full record on ClinicalTrials.gov